World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 8 May 2023
Main ID:  NCT03710538
Date of registration: 20/06/2018
Prospective Registration: Yes
Primary sponsor: Institut de Recherches Cliniques de Montreal
Public title: The Effect of a Pre-meal Snack and/or Exercise on Post-prandial Glycemic Excursions in Adults With Cystic Fibrosis SNACK_CF
Scientific title: The Effect of a Pre-meal Snack and/or Exercise on Post-prandial Glycemic Excursions in Adults With Cystic Fibrosis
Date of first enrolment: April 1, 2019
Target sample size: 14
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03710538
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Single (Participant).  
Phase:  N/A
Countries of recruitment
Canada
Contacts
Name:     RĂ©mi Rabasa-Lhoret, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  IRCM
Key inclusion & exclusion criteria

Inclusion Criteria:

- Diagnosis of cystic fibrosis,

- Be over 18 years old.

Exclusion Criteria:

- Pharmacological treatment for cystic fibrosis related diabetes.

- Signs of secondary infection: the test will be practiced at least 1 month after the
end of infection treatment

- People with severe gastrointestinal illness (Crohn's disease, celiac disease and a
recent history (<1 year) of bowel obstruction).

- Allergy to one of the ingredients of the menu (example: celiac disease)

- According to the judgment of the investigator, medications or conditions that could
interfere with glucose metabolism (eg: oral steroids)

- Pregnancy in progress

- Corrector or potentiator prescribed whose dose is not stable the last 2 months.



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Cystic Fibrosis
Intervention(s)
Behavioral: Exercise
Dietary Supplement: Snack beverage
Primary Outcome(s)
Total area under the curve for plasma glucose [Time Frame: Overall study period (4 hours)]
Secondary Outcome(s)
Area under the curve for plasma glucose [Time Frame: From start of study to breakfast time (1 hour)]
Area under the curve for plasma glucose [Time Frame: From time of breakfast to the end of the study (3 hours)]
Percentage of time with plasma glucose concentration above 10.0 mmol/L [Time Frame: Overall study period (4 hours)]
Area under the curve for insulin [Time Frame: From breakfast time to the end of the study (3 hours)]
Mean insulin [Time Frame: Overall study period (4 hours)]
Percentage of time with plasma glucose concentration above 11.0 mmol/L [Time Frame: Overall study period (4 hours)]
Percentage of time with plasma glucose concentration above 8.0 mmol/L [Time Frame: Overall study period (4 hours)]
Mean plasma glucose [Time Frame: Overall study period (4 hours)]
Percentage of time with plasma glucose concentration below 4.0 mmol/L [Time Frame: Overall study period (4 hours)]
Area under the curve for insulin [Time Frame: From start of study to breakfast time (1 hour)]
Total area under the curve for insulin [Time Frame: Overall study period (4 hours)]
Post-breakfast peak plasma glucose [Time Frame: 1 hour after breakfast]
Secondary ID(s)
SNACK_CF
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history